journal article·2025-09

Bilayer vascular grafts incorporated with S-nitrosated keratin nanoparticles and resveratrol to enhance long-term nitric oxide release and endothelialization

Jie Zhang, Yanlong Wang, Yu Sun, Zeyi Zhou, Fengni Liu, Xinyu Zhang, Chuiyu Kong, Jiang Yuan, Meng Yin, Dongjin Wang

Acta Biomaterialia· Volume 203
Publisher page

Abstract

Intimal hyperplasia, thrombosis formation, and vascular calcification are the leading causes of failure in small-diameter vascular grafts. In the study, bilayer vascular grafts with separately released nitric oxide (NO) and resveratrol (RESV) were fabricated. S-nitrosated keratin nanoparticles (KNPs) were synthesized and subsequently electrospun with poly(ε-caprolactone) (PCL) to prolong the NO release for up to 25 d in the presence of ascorbic acid and trypsin, serving as the inner layer of grafts. Additionally, RESV was incorporated into poly(L-lactide-co-ε-caprolactone) (PLCL) fibers to alleviate oxidative stress and inflammation, acting as the outer layer of the grafts. The PCL/KNPs//PLCL/RESV bilayer grafts were capable of promoting endothelial cell proliferation while inhibiting the excessive proliferation of smooth muscle cells. Notably, bilayer grafts could regulate macrophage polarization toward the M2 phenotype. In rat abdominal aorta replacement models, the grafts retained patency for 3 months. These grafts could accelerate endothelialization without apparent intimal hyperplasia, thrombosis, inflammation, and calcification. These bilayer grafts are promising for small-diameter tissue-engineered vascular grafts. STATEMENT OF SIGNIFICANCE: • S-nitrosated keratin nanoparticles (KNPs) were synthesized and subsequently electrospun to prolong the NO release for 25 d • Resveratrol (RESV) was incorporated into PLCL fibers to alleviate oxidative stress and inflammation. • Bilayer grafts promoted EC proliferation while inhibiting SMC proliferation. • Bilayer grafts accelerated endothelialization without intimal hyperplasia, thrombosis, and calcification in vivo.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Dyeing and Modifying Textile Fibers · Silk-based biomaterials and applications · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (67)

Show source-provided references
1. The burden of cardiovascular risk factors: a global perspective10.1093/eurheartj/ehac430 ↗
2. From arteries to capillaries: approaches to engineering human vasculature
3. Monocyte adhesion to human vein grafts: a marker for occult intraoperative injury?10.1067/mva.2001.118590 ↗
4. Small-diameter vascular tissue engineering10.1038/nrcardio.2013.77 ↗
5. Roles of cells from the arterial vessel wall in atherosclerosis10.1155/2017/8135934 ↗
6. Vascular tissue engineering: challenges and requirements for an ideal large scale blood vessel10.3389/fbioe.2021.721843 ↗
7. Human endothelial cell growth on mussel-inspired nanofiber scaffold for vascular tissue engineering10.1016/j.biomaterials.2010.08.071 ↗
8. Rapid endothelialization of small diameter vascular grafts by a bioactive integrin-binding ligand specifically targeting endothelial progenitor cells and endothelial cells10.1016/j.actbio.2020.03.005 ↗
9. Physico-mechanical and biological evaluation of heparin/VEGF-loaded electrospun polycaprolactone/decellularized rat aorta extracellular matrix for small-diameter vascular grafts10.1080/09205063.2022.2069398 ↗
10. The loading of C-type natriuretic peptides improved hemocompatibility and vascular regeneration of electrospun poly(ε-caprolactone) grafts10.1016/j.actbio.2022.08.032 ↗
11. Nitric oxide and atherosclerosis: an update10.1016/j.niox.2006.03.011 ↗
12. Nitric oxide, is a protective molecule in the cardiovascular system10.1016/j.niox.2013.09.004 ↗
13. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium10.1016/S0006-291X(87)80299-1 ↗
14. Polymers incorporating nitric oxide releasing/generating substances for improved biocompatibility of blood-contacting medical devices10.1016/j.biomaterials.2004.06.006 ↗
15. Local delivery of nitric oxide: targeted delivery of therapeutics to bone and connective tissues10.1016/j.addr.2012.03.002 ↗
16. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension10.1172/JCI200314172 ↗
17. The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics10.1038/nrd2466 ↗
18. Core-shell fibrous vascular grafts with the nitric oxide releasing property10.1007/s11426-010-0096-x ↗
19. A mini-review: needleless electrospinning of nanofibers for pharmaceutical and biomedical applications10.3390/pr8060673 ↗
20. Functional electrospun fibers for the treatment of human skin wounds10.1016/j.ejpb.2017.07.001 ↗
21. Core-shell fibrous vascular grafts with the nitric oxide releasing property10.1007/s11426-010-0096-x ↗
22. Active release of nitric oxide-releasing dendrimers from electrospun polyurethane fibers10.1021/acsbiomaterials.6b00032 ↗
23. In-stent restenosis limitation with stent-based controlled-release nitric oxide: initial results in rabbits
24. Biodegradable polymeric nanoparticles as the delivery carrier for drug10.2174/156720181304160521004609 ↗
25. Drug delivery applications of core-sheath nanofibers prepared by coaxial electrospinning: a review10.3390/pharmaceutics11070305 ↗
26. S-nitrosated keratin composite mats with NO release capacity for wound healing10.1016/j.cej.2020.125964 ↗
27. Nitric oxide release: part I. Macromolecular scaffolds10.1039/c2cs15272j ↗
28. Polymer-based nitric oxide therapies: recent insights for biomedical applications10.1002/adfm.201101707 ↗
29. Smooth muscle cells of intracranial vessels: from development to disease10.1093/cvr/cvy002 ↗
30. Bioinspired PLCL/elastin nanofibrous vascular tissue engineering scaffold enhances endothelial cells and inhibits smooth muscle cells10.1021/acs.biomac.3c00175 ↗
31. Effect of resveratrol on modulation of endothelial cells and macrophages for rapid vascular regeneration from electrospun poly(ε-caprolactone) scaffolds10.1021/acsami.6b16573 ↗
32. Novel nanocomposite stent coating releasing resveratrol and quercetin reduces neointimal hyperplasia and promotes re-endothelialization10.1016/j.jconrel.2012.01.008 ↗
33. Bilayer vascular grafts separately composited with nitric oxide-releasing keratin conjugates and hydrogen sulfide-releasing heparin conjugates
34. Endothelium-mimicking bilayer vascular grafts with dual-releasing of NO/H2S for anti-inflammation and anti-calcification10.1021/acsami.3c15176 ↗
35. Bilayer vascular grafts with on-demand NO and H2S release capabilities10.1016/j.bioactmat.2023.07.020 ↗
36. Extraction, characterization, and NO release potential of keratin from human hair10.1016/j.matlet.2016.04.036 ↗
37. Nitric oxide-releasing poly(ε-caprolactone)/S-nitrosylated keratin biocomposite scaffolds for potential small-diameter vascular grafts10.1016/j.ijbiomac.2021.08.147 ↗
38. Preparation and characterization of DOX loaded keratin nanoparticles for pH/GSH dual responsive release10.1016/j.msec.2016.12.067 ↗
39. Preparation of nanoparticles of poorly water-soluble antioxidant curcumin by antisolvent precipitation methods10.1007/s11051-012-0757-0 ↗
40. Keratin: dissolution, extraction and biomedical application10.1039/C7BM00411G ↗
41. Construction of enzyme-laden vascular scaffolds based on hyaluronic acid oligosaccharides-modified collagen nanofibers for antithrombosis and in-situ endothelialization of tissue-engineered blood vessels10.1016/j.actbio.2022.09.041 ↗
42. The influence of fiber diameter of electrospun poly(lactic acid) on drug delivery10.1007/s12221-012-1120-x ↗
43. Protective role of endothelial nitric oxide synthase10.1002/path.1250 ↗
44. Vascular smooth muscle cells in intimal hyperplasia, an update10.3389/fphys.2022.1081881 ↗
45. Nitric oxide-enhancing or -releasing agents as antithrombotic drugs10.1016/j.bcp.2019.05.030 ↗
46. Resveratrol increases vascular oxidative stress resistance10.1096/fasebj.21.5.A444-c ↗
47. Antishear stress bionic carbon nanotube mesh coating with intracellular controlled drug delivery constructing small-diameter tissue–Engineered vascular grafts10.1002/adhm.201800026 ↗
48. Antioxidants, oxidants and free radical stress in cardiovascular disease
49. Oxidative stress and cardiovascular disease: new insights10.5603/KP.a2018.0071 ↗
50. Redox control of vascular smooth muscle proliferation10.1016/S0022-2143(98)90019-1 ↗
51. Inhibition of reactive oxygen species generation attenuates TLR4-mediated proinflammatory and proliferative phenotype of vascular smooth muscle cells10.1038/labinvest.2013.79 ↗
52. Novel antioxidant peptides derived from feather keratin alleviate H2O2-induced oxidative damage in HepG2 cells via Keap1/Nrf2 pathway10.1021/acs.jafc.3c05088 ↗
53. Resveratrol improves cognition and reduces oxidative stress in rats with vascular dementia
54. Macrophage plasticity, polarization, and function in health and disease10.1002/jcp.26429 ↗
55. Unsaturated polyurethane films grafted with enantiomeric polylysine promotes macrophage polarization to a M2 phenotype through PI3K/Akt1/mTOR axis10.1016/j.biomaterials.2020.120012 ↗
56. Resveratrol inhibits the proliferation of A549 cells by inhibiting the expression of COX-210.2147/OTT.S157613 ↗
57. Suppression of ultraviolet B exposure-mediated activation of NF-κb in normal human keratinocytes by resveratrol10.1016/S1476-5586(03)80019-2 ↗
58. Resveratrol: one molecule, many targets10.1002/iub.47 ↗
59. Recent advances on the anti-inflammatory and antioxidant properties of red grape polyphenols: in vitro and in vivo studies10.3390/antiox9010035 ↗
60. M2 macrophage polarization mediates anti-inflammatory effects of endothelial nitric oxide signaling10.2337/db14-1668 ↗
61. Effects of selected resveratrol analogues on activation and polarization of lipopolysaccharide-stimulated BV-2 microglial cells10.1021/acs.jafc.0c00498 ↗
62. Nitric oxide regulates vascular calcification by interfering with TGF-β signaling10.1093/cvr/cvm049 ↗
63. Resveratrol ameliorated vascular calcification by regulating sirt-1 and Nrf210.1016/j.transproceed.2016.10.023 ↗
64. Angiotensin II induces the differentiation of mouse epicardial progenitor cells into vascular smooth muscle-like cells10.1016/j.bbrc.2016.10.122 ↗
65. Proteomic analysis of vascular smooth muscle cells in physiological condition and pulmonary arterial hypertension: toward contractile versus synthetic phenotypes10.1002/pmic.201500006 ↗
66. Smooth muscle differentiation is essential for airway size, tracheal cartilage segmentation, but dispensable for epithelial branching10.1016/j.devcel.2020.02.001 ↗
67. Nitric oxide releasing delivery platforms: design, detection, biomedical applications, and future possibilities10.1021/acs.molpharmaceut.1c00486 ↗